This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Molecular Defenses Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Kevin Davis - Innovator in Glutathione Formulation
Introduction
Kevin Davis is a notable inventor based in New York, NY (US). He has made significant contributions to the field of health and medicine through his innovative work on glutathione formulations. His research focuses on the use of glutathione to combat various health threats, including viral and bacterial agents.
Latest Patents
Kevin Davis holds a patent for a glutathione formulation and method of use. This patent outlines the application of glutathione to treat or prevent injuries caused by viral, bacterial, chemical, and nuclear agents. The formulation is designed as an oral dosage form, utilizing reduced glutathione stabilized by ascorbic acid. This innovative approach ensures high oral bioavailability and minimizes oxidation during packaging and storage.
Career Highlights
Kevin Davis is associated with Molecular Defenses Corporation, where he continues to develop and refine his groundbreaking formulations. His work is pivotal in advancing therapeutic options for individuals exposed to harmful agents.
Collaborations
One of his notable coworkers is Harry B Demopoulos, who collaborates with Davis on various projects within the company.
Conclusion
Kevin Davis's contributions to the field of glutathione formulations highlight his commitment to improving health outcomes through innovative solutions. His work exemplifies the impact of scientific research on public health and safety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile